A. Del Franco

C. Autore, M. Emdin, C. Di Mario, 2020, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Creatine deficiency and heart failure

M. Emdin, M. Metra, F. Recchia, 2021, Heart Failure Reviews.

In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation

M. Emdin, S. Burchielli, C. Passino, 2022, Journal of Cardiovascular Translational Research.

Prognostic role of isolated left ventricular diverticuli detected by cardiovascular magnetic resonance

G. Aquaro, M. Lombardi, G. Todiere, 2015, Journal of cardiovascular medicine.

Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation.

I. Olivotto, E. Pálinkás, M. Zampieri, 2022, International journal of cardiology.

Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not

C. Mazzoni, C. Di Mario, A. Tomberli, 2022, Biomedicines.

Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis

R. Ferrari, G. Campo, F. D’Ascenzo, 2016, COPD.

Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure.

M. Emdin, C. Passino, G. Iudice, 2016, International journal of cardiology.

Abnormal T2-STIR Magnetic Resonance in Hypertrophic Cardiomyopathy: A Marker of Advanced Disease and Electrical Myocardial Instability

M. Emdin, G. Aquaro, M. Lombardi, 2014, PloS one.

Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy.

M. Emdin, G. Aquaro, L. Padeletti, 2015, International journal of cardiology.

Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease

R. Ferrari, G. Campo, F. Gallo, 2017, Thrombosis and Haemostasis.

Ticagrelor Improves Endothelial Function by Decreasing Circulating Epidermal Growth Factor (EGF)

R. Ferrari, G. Campo, R. Pavasini, 2018, Front. Physiol..

Stage-specific therapy for hypertrophic cardiomyopathy

C. Mazzoni, I. Olivotto, F. Cecchi, 2023, European heart journal supplements : journal of the European Society of Cardiology.

Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction

M. Emdin, C. Passino, C. Prontera, 2023, BMC Cardiovascular Disorders.

The evolving paradigm and current perception of hypertrophic cardiomyopathy: Implications for management.

I. Olivotto, A. Tomberli, M. Zampieri, 2023, Progress in cardiovascular diseases.

Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan

G. Pedrizzetti, M. Emdin, G. Tonti, 2023, ESC heart failure.

Treating chemoreflex in heart failure: modulation or demolition?

M. Emdin, C. Passino, A. Giannoni, 2014, The Journal of physiology.